Nestle expects FY24 organic sales growth around 4% and a moderate increase in the underlying trading operating profit margin. Underlying earnings per share in constant currency is expected to increase between 6% and 10%.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NSRGY:
- NSRGY Earnings: Nestlé Posts Tepid Outlook as Inflation Bites
- GLP-1 Anti-Obesity Drugs: Slim Waistlines, Fat Profits
- Nestle downgraded to Underperform from Neutral at Exane BNP Paribas
- Codexis enters into purchase agreement with Nestle Health Science for CDX-7108
- Codexis enters into pruchase agreement with Nestle Health Science for CDX-7108